MSCs were found to inhibit mouse tumours both in vivo and in vitro by up-regulating the mRNA expression of p21, a negative regulator of the tumour cell cycle, and the expression of caspase 3, an apoptosis-related protease. Here, CASP3 is linked to neoplasm.